Issue 33, 2021

Hydrogel, a novel therapeutic and delivery strategy, in the treatment of intrauterine adhesions

Abstract

Intrauterine adhesions (IUAs) are caused by damage to the underlying lining of the endometrium. They’ re related to disorder of endometrial repair. In recent years, hydrogels with controllable biological activity have been widely used for treating IUAs. They encapsulate estrogen, cytokines, cells, or exosomes, forming a delivery system to release therapeutic components for the treatment of IUAs. In addition, the hydrogel acting as a barrier can be degraded in the body automatically, reducing the risk of infection caused by secondary surgeries. In this review, we summarize the recent progress of hydrogels and their application in IUAs as both a novel alternative therapeutic and an artificial delivery strategy.

Graphical abstract: Hydrogel, a novel therapeutic and delivery strategy, in the treatment of intrauterine adhesions

Article information

Article type
Review Article
Submitted
05 mai 2021
Accepted
16 juil. 2021
First published
22 juil. 2021

J. Mater. Chem. B, 2021,9, 6536-6552

Hydrogel, a novel therapeutic and delivery strategy, in the treatment of intrauterine adhesions

H. Lv, B. Wu, J. Song, W. Wu, W. Cai and J. Xu, J. Mater. Chem. B, 2021, 9, 6536 DOI: 10.1039/D1TB01005K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements